U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07272655) titled 'Hemiarch vs. Total Arch With FET for Type A Aortic IMH' on Nov. 26.
Brief Summary: This is a prospective, randomized, double-blind, non-inferiority clinical trial designed to compare the efficacy and safety of two surgical strategies for Type A aortic intramural hematoma (TAIMH): (1) Ascending aorta /hemiarch replacement (A/HAR), and (2) Ascending aorta with total arch replacement and frozen elephant trunk (TARFET).
Patients with acute TAIMH will be enrolled based on computed tomography angiography (CTA) confirmation of a completely thrombosed false lumen in the ascending aorta and aortic arch. Eligible participants will be randoml...